Breast Cancer Trial, Recruiting NCT05346510 Sponsor: Shengjing Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05346510
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a chest CT scan and an axillary Doppler ultrasound (a scan of the lymph node area near the armpit) taken while lying face-down before surgery
  • People who have had a full surgical removal of the lymph nodes in the armpit area (known as axillary lymph node dissection)
  • People who are able to attend regular follow-up appointments after surgery, both in the short term and long term

Who may not be able to join:

  • People who have a history of another cancer or non-cancerous tumour that has caused swelling or enlargement of the lymph nodes in the armpit area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jianyi Li, Dr, Cancer Hospital of China Medical University, Liaoning Cancer Hospital

Phone: 8618940257177

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shengjing Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
1 September 2022

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Agreement rates with postoperative histology

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov